Pulmonary Hypertension News and Research

RSS
Pulmonary arterial hypertension (PAH) is a condition involving high blood pressure and structural changes in the walls of the pulmonary arteries, which are the blood vessels that connect the right side of the heart to the lungs. Affecting people of all ages and ethnic backgrounds - but most commonly found in young women of child-bearing years - the disease has historically been chronic and incurable, with a poor survival rate. PAH is often not diagnosed in a timely manner because its early symptoms can be confused with those of many other pulmonary and respiratory conditions. Symptoms include shortness of breath, extreme fatigue, dizziness, fainting, swollen ankles and legs and chest pain (especially during physical activity). With proper diagnosis, there are currently several therapies to alleviate symptoms and improve quality of life for PAH patients. The key is to find a PAH specialist and pursue immediate treatment.
MMRI professor receives $3.7 million NIH grant to support research on pulmonary embolism

MMRI professor receives $3.7 million NIH grant to support research on pulmonary embolism

Understanding the role of TIPS in improving renal function amid cirrhosis

Understanding the role of TIPS in improving renal function amid cirrhosis

New guidelines for cardiovascular management in noncardiac surgery released

New guidelines for cardiovascular management in noncardiac surgery released

Coordinated health teams may help improve outcomes for children with Trisomy 21 and heart conditions

Coordinated health teams may help improve outcomes for children with Trisomy 21 and heart conditions

Protein encoded by the ASPN gene plays a protective role in pulmonary arterial hypertension

Protein encoded by the ASPN gene plays a protective role in pulmonary arterial hypertension

First-ever successful use of modified double-decker technique for scimitar syndrome in a child

First-ever successful use of modified double-decker technique for scimitar syndrome in a child

Plant-derived substance shows promise against pulmonary hypertension

Plant-derived substance shows promise against pulmonary hypertension

Injectable fish oil emulsion reduces brain damage in newborn rodents

Injectable fish oil emulsion reduces brain damage in newborn rodents

Long COVID linked to higher risk of erectile dysfunction, new study finds

Long COVID linked to higher risk of erectile dysfunction, new study finds

Study reveals benefits of hormone replacement therapy in female pulmonary hypertension patients

Study reveals benefits of hormone replacement therapy in female pulmonary hypertension patients

Study finds accounting for sex improves precision and prognostic performance of CMR biomarkers for heart failure

Study finds accounting for sex improves precision and prognostic performance of CMR biomarkers for heart failure

New discovery offers dietary solution for pulmonary hypertension

New discovery offers dietary solution for pulmonary hypertension

UCSF scientists discover less invasive prenatal treatment for Angelman syndrome

UCSF scientists discover less invasive prenatal treatment for Angelman syndrome

Genetic studies shed light on hypertension risk but fall short of revealing new treatments

Genetic studies shed light on hypertension risk but fall short of revealing new treatments

Understanding the role played by HIV in pulmonary hypertension

Understanding the role played by HIV in pulmonary hypertension

Study reveals limited access to pulmonary rehabilitation for millions of Americans

Study reveals limited access to pulmonary rehabilitation for millions of Americans

Low-frequency ultrasound influences blood parameters, reserach shows

Low-frequency ultrasound influences blood parameters, reserach shows

Scientists discover a possible therapeutic target for pulmonary hypertension

Scientists discover a possible therapeutic target for pulmonary hypertension

The crucial need for ongoing COVID-19 booster vaccination in vulnerable populations

The crucial need for ongoing COVID-19 booster vaccination in vulnerable populations

Researchers harness the power of AI to enhance assessment of the heart's right ventricle

Researchers harness the power of AI to enhance assessment of the heart's right ventricle

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.